Physician profile
Morton Zinberg
NPI 1902960099
$334.15
in general payments reported to CMS, 2019-2025
14 companies · $54.62 in 2025
The $54.62 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.86 · 2020: $10.99 · 2021: $35.46 · 2022: $101 · 2023: $43.27 · 2024: $13.63 · 2025: $54.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $111.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $46.64 | 2019-2021 | |
| Ucb, INC. | $43.81 | 2019 | |
| Pfizer INC. | $32.15 | 2022 | |
| Janssen Biotech, INC. | $27.94 | 2022 | |
| Sun Pharmaceutical Industries INC. | $27.21 | 2023 | Winlevi |
| Amgen INC. | $25.18 | 2022 | |
| Incyte Corporation | $20.28 | 2025 | Opzelura |
| Epi Health, LLC | $19.87 | 2019 | |
| Organon LLC | $19.47 | 2025 | |
| Lilly USA, LLC | $16.06 | 2023 | Olumiant |
| Biofrontera INC. | $16.05 | 2022 | |
| Mimedx Group, INC. | $14.87 | 2025 | |
| Verrica Pharmaceuticals INC. | $13.63 | 2024 | Ycanth |
| Encore Dermatology INC. | $10.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morton Zinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.